Literature DB >> 23134551

Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase.

Sibylle Gündisch1, Stefanie Hauck, Hakan Sarioglu, Christina Schott, Christian Viertler, Marcel Kap, Tibor Schuster, Bilge Reischauer, Robert Rosenberg, Cornelis Verhoef, Hans-Joerg Mischinger, Peter Riegman, Kurt Zatloukal, Karl-Friedrich Becker.   

Abstract

The quality of human tissue specimens can have a significant impact on analytical data sets for biomarker research. The aim of this study was to characterize fluctuations of protein and phosphoprotein levels in human tissue samples during the preanalytical phase. Eleven intestine and 17 liver specimens were surgically resected, aliquoted, and either snap-frozen or fixed in formalin immediately or exposed to different ischemic conditions before preservation. Protein levels in the resultant samples were investigated by reverse phase protein array, Western blot analysis, and liquid chromatography-tandem mass spectrometry. Our data revealed that the degree of sensitivity of proteins and phosphoproteins to delayed preservation varied between different patients and tissue types. For example, up-regulation of phospho-p42/44 MAPK in intestine samples was seen in some patients but not in others. General trends toward up- or down-regulation of most proteins were not evident due to pronounced interpatient variability but signal intensities of only a few proteins, such as cytokeratin 18, were altered from baseline in postresection samples. In contrast, glyceraldehyde 3-phosphate dehydrogenase was found to be stable during periods of cold ischemia. Our study represents a proper approach for studying potential protein fluctuations in tissue specimens for future biomarker development programs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134551     DOI: 10.1021/pr300560y

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  23 in total

1.  Biological, Medical, and Other Tissue Variables Affecting Biospecimen Utilization.

Authors:  Dennis Otali; Sameer Al Diffalha; William E Grizzle
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

2.  Improved immunohistochemical detection of phosphorylated mitogen-activated protein kinases in the injured rat optic nerve head.

Authors:  Teresa Mammone; Glyn Chidlow; Robert J Casson; John P M Wood
Journal:  Histochem Cell Biol       Date:  2019-03-11       Impact factor: 4.304

Review 3.  Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.

Authors:  Lokesh Agrawal; Kelly B Engel; Sarah R Greytak; Helen M Moore
Journal:  Semin Cancer Biol       Date:  2017-12-16       Impact factor: 15.707

Review 4.  [Preanalytics and biobanking : Influence of preanalytical factors on tissue sample quality].

Authors:  K-F Becker; J Wipperfürth; E Herpel
Journal:  Pathologe       Date:  2018-07       Impact factor: 1.011

5.  Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.

Authors:  Carine Steiner; Jean-Christophe Tille; Jens Lamerz; Sabine Kux van Geijtenbeek; Thomas A McKee; Miro Venturi; Laura Rubbia-Brandt; Denis Hochstrasser; Paul Cutler; Pierre Lescuyer; Axel Ducret
Journal:  Mol Cell Proteomics       Date:  2015-07-06       Impact factor: 5.911

6.  Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.

Authors:  Philipp Mertins; Feng Yang; Tao Liu; D R Mani; Vladislav A Petyuk; Michael A Gillette; Karl R Clauser; Jana W Qiao; Marina A Gritsenko; Ronald J Moore; Douglas A Levine; Reid Townsend; Petra Erdmann-Gilmore; Jacqueline E Snider; Sherri R Davies; Kelly V Ruggles; David Fenyo; R Thomas Kitchens; Shunqiang Li; Narciso Olvera; Fanny Dao; Henry Rodriguez; Daniel W Chan; Daniel Liebler; Forest White; Karin D Rodland; Gordon B Mills; Richard D Smith; Amanda G Paulovich; Matthew Ellis; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2014-04-09       Impact factor: 5.911

7.  Tissue resources for clinical use and marker studies in melanoma.

Authors:  Jonathan L Curry; Michael A Davies; Tiffany L Calderone; Katherine Nathanson; Victor G Prieto; Jeffrey E Gershenwald
Journal:  Methods Mol Biol       Date:  2014

Review 8.  Effects of Cold Ischemia on Gene Expression: A Review and Commentary.

Authors:  William E Grizzle; Dennis Otali; Katherine C Sexton; Daniel S Atherton
Journal:  Biopreserv Biobank       Date:  2016-08-23       Impact factor: 2.300

Review 9.  Antibody validation: a view from the mountains.

Authors:  Michael J Taussig; Cláudia Fonseca; James S Trimmer
Journal:  N Biotechnol       Date:  2018-08-04       Impact factor: 5.079

10.  Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.

Authors:  Marika Doucet; Karl Friedrich Becker; Jens Björkman; Jacques Bonnet; Bruno Clément; Maria-Grazia Daidone; Charles Duyckaerts; Gilles Erb; Helmuth Haslacher; Paul Hofman; Berthold Huppertz; Christophe Junot; Joakim Lundeberg; Andres Metspalu; Marialuisa Lavitrano; Jan-Eric Litton; Helen M Moore; Manuel Morente; Ben-Youssef Naimi; Uwe Oelmueller; Bill Ollier; Barbara Parodi; Liangliang Ruan; Giorgio Stanta; Paola Turano; Jim Vaught; Peter Watson; H-Erich Wichmann; Martin Yuille; Myriam Zaomi; Kurt Zatloukal; Georges Dagher
Journal:  Biopreserv Biobank       Date:  2016-12-19       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.